ACE and heart failure: Although heart failure therapies in the community had the second-largest contribution to deaths prevented or postponed, previous studies in Mexico suggest that the doses of angiotensin convert enzyme (ACE), spironolactone, and beta-blockers are not optimal [51, 52].